XXXX due to @entity15627 .

@entity1 @entity1671 @entity1569 @entity1910 @entity56 @entity15627
OBJECTIVE: To report a case of an unusual skin reaction to @entity15627 (FAE). CASE SUMMARY: A 68-year-old white @entity1 who was treated with FAE for 4 days for lichen planus developed generalized @entity1910 . This was suspected to be an @entity56 drug reaction to FAE, and the treatment was discontinued. After 48-72 hours, the @entity1910 resolved completely. An objective causality assessment revealed that the adverse drug event was probable. As skin testing for diagnostic purposes is not feasible with FAE, the drug-related origin of the @entity1910 was confirmed by oral rechallenge with FAE. DISCUSSION: The effectiveness of FAE in the systemic treatment of @entity1569 has been proven by controlled clinical trials. The compound has been shown to be tolerable and safe even during prolonged treatment. The most frequent adverse effects are gastrointestinal symptoms and @entity1671 , which typically occur 4-6 hours after administration of the drug. @entity56 to FAE have not yet been reported. Since the @entity1 was rechallenged with the suspected drug, we could confirm the @entity56 origin of the @entity1910 . CONCLUSIONS: The occurrence of @entity56 skin reaction should be considered in @entity1 receiving treatment with FAE.
